evolution of BCoVs, suggesting a successful mechanism for BCoV to continuously circulate 48 among cattle and other ruminants without disappearance. 49 50 INTRODUCTION terminal domain (Abraham et al., 1990) . The S1 subunit is a peripheral protein, mediating virus 74 binding to host-cell receptors (Li, 2012; Peng et al., 2012) , haemagglutinating activity (Schultze 75 et al., 1991) and inducing neutralizing antibodies (Yoo & Deregt, 2001) . The S2 subunit is a 76 transmembrane protein which mediates fusion of viral and cellular membranes (Yoo et al., 77 1991a) . 78 79 BCoV is the causative agent of neonatal calf diarrhea (CD), winter dysentery (WD) in adult 80 cattle (Alenius et al., 1991; Mebus et al., 1973; Saif et al., 1988) , and respiratory tract disorders 81 in cattle of all ages (Cho et al., 2001; Decaro et al., 2008a; Lathrop et al., 2000) . This infection is 82 not effectively controlled in the herds by current commercial vaccines (Saif, 2010) . BCoV 83 negatively impacts cattle industry due to reduced milk production, loss of body condition and 84 also through the death of young animals (Clark, 1993; Saif, 2010) . BCoV outbreaks most often 85 happen during fall and winter (Clark, 1993) . However, studies from various climate regions have 86 also reported BCoV outbreaks in the warmer seasons (Bidokhti et al., 2012; Decaro et al., 87 2008b; Park et al., 2006) . 88 89 Studies have shown high prevalence of BCoV infections in cattle farms in many countries 90 (Fulton et al., 2011; Paton et al., 1998; Saif, 2010; Tråvén et al., 2001) . Also BCoV-like 91 coronaviruses transmissible to gnotobiotic calves have been found among various wild ruminants 92 (Alekseev et al., 2008; Tsunemitsu et al., 1995) . The public health impact of BCoVs has also 93 been raised due to the isolation of a BCoV-like human enteric coronavirus -4408/US/94 94 (HECV-4408/US/94) from a child with acute diarrhoea (Zhang et al., 1994) , and also the 95 outbreaks of severe acute respiratory syndrome CoV (SARS-CoV) (Groneberg et al., 2003; 96 The analysis of the predicted S proteins of the present 33 BCoV strains revealed a potential N-139 terminal signal peptide of about 14 amino acids by SignalP-HMM and SignalP-NN, respectively. 140 A potential S1/S2 cleavage site located after RRSRR, identical for BCoV (Abraham et al., 1990) The analyzed samples showed low variability. Within the 4092 nt of the complete sequences of 157 the S protein gene, 340 nt were variable (8.3%). At the aa level the variation was slightly larger 158 (147 variable aa residues, 10.8%). Nucleotide p-distances among strains ranged between 0.1 and 159 2.7%. This high degree of sequence identity is reflected in the NJ tree ( Fig. 1 and ECoV clusters were more distant (Fig. 1) . 167 168 Fifty-three nt differences were found between strains SWE/M/06-3 and SWE/M/06-4 (98.7% nt 169 similarity, 98.1% aa similarity). These strains were obtained from two dairy herds with CD 170 symptoms sampled at the same time in southern Sweden. SWE/M/06-3 clustered with 171 SWE/AC/08-1, SWE/E/08-2, SWE/Z/07-1, SWE/C/07-2, SWE/C/07-6 and SWE/U/09-3 ( Fig.1 (Table 3) . and 495-527 of the S1 subunit were under strong positive selection ( Fig. 2a ). Amino acid 206 residues 36-97, 315-420, 498-713, 910-1032, 1059-1234 and 1245-1279 were under negative 207 selection. They covered most of the S2 subunit, indicating that S2 is relatively stable in BCoV 208 ( Fig. 2a ). 209
210
The SNAP analysis identified 133 positively selected sites. 89 of them are in S1 and 44 in S2 211 domain ( Fig. 2b) . Several of these sites were also identified by the REL method at posterior 212 probability p > 90% level. The following positive selection sites were identified by SNAP and 213 REL methods: 35, 112, 113, 115, 143, 147, 151, 157, 188, 257, 447, 458, 471, 482, 499, 501, 214 503, 510, 523, 525, 543, 546, 573, 578, 590, 596, 718, 722, 888, and 1239 (Table 4) . Default parameters were used in I-TASSER to predict structures of these proteins as explained in 235 the Materials and Methods section. Results indicated that NTD and putative C-domain of S1 236 were structurally similar for HECV-4408/US/94 and SWE/C/92 ( Fig. 3a, b ). This similarity is 237 clearly illustrated when the two structures are aligned ( Fig. 3c ). In contrast, the predicted 238 structures for SWE/M/10-1, and GER/V270/83 were substantially divergent while DEN/03-3 239
shows an intermediate conformation ( Fig. 3d-f ). Also in the S2 region HECV-4408/US/94 and 240 SWE/C/92 differed in conformation compared to the other strains. The residues primarily 241 predicted as potential receptor binding sites based on homology with the S protein of SARS were 242 used in the generation of structural models. Notably, parts of the putative receptor binding 243 domain and of the NTD were found to be in the strong positively selected regions on the surface 244 of S1 subunit ( Fig. 3g , residues coloured green and red in SWE/C/92). The selection profiles identified two main patterns within the subunit domains S1 and S2 of the S 327 protein. The S1 subunit is exposed on the surface of the viral particle, and is the target of 328 selected sites along S1 subunit identified in this study and mapped neutralizing epitopes. 334
Epitopic fragments spanning aa residues 324-720 of the S1 subunit of BCoV and the N-terminus 335 of the S2 subunit spanning aa residues 769-798 have been previously recognized using 336 monoclonal antibodies (MAbs) (Vautherot et al., 1992a; Yoo et al., 1991b) . A polymorphic 337 region spanning aa residues 456-592 has also been shown by sequence analysis of BCoV strains 338 (Rekik & Dea, 1994) . It has been reported that mutations in the S1 and the N-terminus of the S2 339 selection pattern of the S2 subunit is also reported (Fig. 2) . Negative selection is usually reported 346 in genome fragments with essential functions in the viral lifecycle (Yang, 2005) . For example, 347 extensive syncytia formation was observed in cells infected with an S2 recombinant of BCoV 348 (Yoo et al., 1991a) . The structure of the SARS-CoV S2 fusion protein core has been shown to 349 provide a framework for the design of entry inhibitors that could be used in the therapeutic 350 intervention against this virus (Supekar et al., 2004) . Thus we speculate that the S2 subunit, 351 except its N-terminus, would mostly interact with cellular compartments rather than immune 352 system elements of the host. ancestor (tMRCA) and the 95% confidence interval (CI) were calculated, and the best-fitting 460 models were selected by a Bayes factor using marginal likelihoods implemented in Tracer 461 (Suchard et al., 2001) . 462 463
In silico model analysis. Based on strain sequence identity and phylogenetic analysis, the aa 464 sequences of the S protein of five CoVs were chosen: HECV-4408/US/94 (the human isolate 465 most closely related to BCoV) and SWE/C/92 (the oldest Swedish strain clustered with HECV-466 4408/US/94), DEN/03-3 (the strain with highest identity to SWE/C/92), SWE/M/10-1 (the strain 467 with lowest identity to SWE/C/92), and GER/V270/83 (a bovine reference isolate from 468 Germany). Initially, a metathreading approach was applied in I-TASSER (Zhang, 2008; Zhang & 469 Skolnick, 2004a), to identify templates for the subjected sequences in a non-redundant protein 470 data bank structure library. From the generated consensus threading templates, the fragments of 471 the sequences were assembled using modified replica-exchange Monte-Carlo simulations into 472 3D models. In order to refine overall topology, models were clustered in SPICKER (Zhang & 473 Skolnick, 2004b) . A C-score was defined based on the quality of the threading alignments and 
